Abstract
Clinical Pharmacology & TherapeuticsVolume 92, Issue 6 p. 694-694 Letters to the Editor Drug Labels: A Flawed Source of Data for Studying Orphan Drug Approvals A S Kesselheim, Corresponding Author A S Kesselheim [email protected] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USASearch for more papers by this authorJ Avorn, J Avorn Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USASearch for more papers by this author A S Kesselheim, Corresponding Author A S Kesselheim [email protected] Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USASearch for more papers by this authorJ Avorn, J Avorn Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USASearch for more papers by this author First published: 17 October 2012 https://doi.org/10.1038/clpt.2012.166Citations: 1Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article.Citing Literature Volume92, Issue6EpigeneticsDecember 2012Pages 694-694 RelatedInformation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
